An overview of clinical studies on SARS-CoV-2 infection in dialysis patients
10.3760/cma.j.cn441217-20230120-00117
- VernacularTitle:透析患者新型冠状病毒感染的临床研究现状
- Author:
Zuolin LI
1
;
Mingming PAN
;
Guihua WANG
;
Qing YIN
;
Anran SHEN
;
Qin YANG
;
Bicheng LIU
Author Information
1. 东南大学附属中大医院肾内科/东南大学肾脏病研究所，南京 210009
- Keywords:
COVID-19;
SARS-CoV-2;
Dialysis;
Clinical manifestations;
Risk factors;
Vaccination;
Therapeutics
- From:
Chinese Journal of Nephrology
2023;39(11):860-866
- CountryChina
- Language:Chinese
-
Abstract:
The global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a catastrophic impact on human life and economic life. Due to the combination of multiple underlying diseases and low vaccination rates, dialysis patients are susceptible to SARS-CoV-2 infection and are likely to have more severe illness and even death. Moreover, dialysis patients with SARS-CoV-2 infection may initially present as asymptomatic or with mild symptoms, which makes it very difficult to identify severe patients at an early stage. Here, the epidemiology, clinical characteristics, risk factors for prognosis, vaccination and therapeutic strategies of dialysis patients with SARS-CoV-2 infection were summarized and analyzed, and it is hoped to provide a reference for the diagnosis and treatment of SARS-CoV-2 infection in this special group of patients.
